SlideShare a Scribd company logo
1 of 2
Dsh
Sclerostin
Wnt
TCF
β-catenin
PAPC
Axin
GSK3
FrizzledLrp5/6 Bone remodeling plays a role in cartilage
homeostasis (Funck-Brentano et al, 2011)
Role of Sclerostin in cartilage
maintenance and in OA ?
Nucleus
Sclerostin is a main regulator of bone formation
Wnt in Bone and Cartilage
Provided by: Wafa BouazizProvided by: Wafa Bouaziz
Mature
chondrocyte
Hypertrophic
chondrocyte
Wnt3a
Wnt3a
Col X
Col II, SOX9 and Aggrecan
ADAMTS-4 & 5, MMP3 and MMP13
Sclerostin
Sclerostin
Summary
Sclerostin preserves chondrocyte maintenance by the inhibition of
chondrocyte catabolism and hypertrophy.
Wnt and its antagonists might be promising targets in studying
cartilage homeostasis in osteoarthritis.
Provided by: Wafa Bouaziz

More Related Content

More from OARSI

Statistical Review of Basic Science Manuscripts at Osteoarthritis and Cartila...
Statistical Review of Basic Science Manuscripts at Osteoarthritis and Cartila...Statistical Review of Basic Science Manuscripts at Osteoarthritis and Cartila...
Statistical Review of Basic Science Manuscripts at Osteoarthritis and Cartila...OARSI
 
Imaging of Synovitis in OA
Imaging of Synovitis in OAImaging of Synovitis in OA
Imaging of Synovitis in OAOARSI
 
Nuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analyses
Nuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analysesNuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analyses
Nuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analysesOARSI
 
Osteoarthriits Imaging: 2018 Year in Review
Osteoarthriits Imaging: 2018 Year in ReviewOsteoarthriits Imaging: 2018 Year in Review
Osteoarthriits Imaging: 2018 Year in ReviewOARSI
 
Vincent the Lumper!
Vincent the Lumper!Vincent the Lumper!
Vincent the Lumper!OARSI
 
OA White Paper: Broader Implications for Advocacy, Health Policy & Research
OA White Paper: Broader Implications for Advocacy, Health Policy & ResearchOA White Paper: Broader Implications for Advocacy, Health Policy & Research
OA White Paper: Broader Implications for Advocacy, Health Policy & ResearchOARSI
 
Structural Targets for Prevention of Post Traumatic OA
Structural Targets for Prevention of Post Traumatic OAStructural Targets for Prevention of Post Traumatic OA
Structural Targets for Prevention of Post Traumatic OAOARSI
 
Building a translational team for impacting public policy Pre-Congress Worksh...
Building a translational team for impacting public policyPre-Congress Worksh...Building a translational team for impacting public policyPre-Congress Worksh...
Building a translational team for impacting public policy Pre-Congress Worksh...OARSI
 
An industry point of view for building a translational team
An industry point of view for building a translational teamAn industry point of view for building a translational team
An industry point of view for building a translational teamOARSI
 
Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, a...
Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, a...Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, a...
Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, a...OARSI
 
Understanding the Accelerated Pathway
Understanding the Accelerated PathwayUnderstanding the Accelerated Pathway
Understanding the Accelerated PathwayOARSI
 
Approval of Therapeutics for Osteoarthritis in 2019
Approval of Therapeutics for Osteoarthritis in 2019Approval of Therapeutics for Osteoarthritis in 2019
Approval of Therapeutics for Osteoarthritis in 2019OARSI
 
YEAR IN REVIEW - Genetics, Genomics, Epigenetics
YEAR IN REVIEW - Genetics, Genomics, EpigeneticsYEAR IN REVIEW - Genetics, Genomics, Epigenetics
YEAR IN REVIEW - Genetics, Genomics, EpigeneticsOARSI
 
Year in review - Biochemical markers
Year in review - Biochemical markersYear in review - Biochemical markers
Year in review - Biochemical markersOARSI
 
Year in Review: Mechanics
Year in Review: MechanicsYear in Review: Mechanics
Year in Review: MechanicsOARSI
 
Rehabilitation and Outcomes - Year in Review
Rehabilitation and Outcomes - Year in ReviewRehabilitation and Outcomes - Year in Review
Rehabilitation and Outcomes - Year in ReviewOARSI
 
Clinical OA: Epidemiology and Therapy - Year in Review
Clinical OA: Epidemiology and Therapy - Year in ReviewClinical OA: Epidemiology and Therapy - Year in Review
Clinical OA: Epidemiology and Therapy - Year in ReviewOARSI
 
2020 OA Vision: Emerging Therapeutics on the OA landscape
2020 OA Vision: Emerging Therapeutics on the OA landscape2020 OA Vision: Emerging Therapeutics on the OA landscape
2020 OA Vision: Emerging Therapeutics on the OA landscapeOARSI
 
Is osteoarthritis one disease or many?
Is osteoarthritis one disease or many? Is osteoarthritis one disease or many?
Is osteoarthritis one disease or many? OARSI
 
Early OA OUTCOMES: What should the targets be?
Early OA OUTCOMES:  What should the targets be?Early OA OUTCOMES:  What should the targets be?
Early OA OUTCOMES: What should the targets be?OARSI
 

More from OARSI (20)

Statistical Review of Basic Science Manuscripts at Osteoarthritis and Cartila...
Statistical Review of Basic Science Manuscripts at Osteoarthritis and Cartila...Statistical Review of Basic Science Manuscripts at Osteoarthritis and Cartila...
Statistical Review of Basic Science Manuscripts at Osteoarthritis and Cartila...
 
Imaging of Synovitis in OA
Imaging of Synovitis in OAImaging of Synovitis in OA
Imaging of Synovitis in OA
 
Nuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analyses
Nuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analysesNuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analyses
Nuts & Bolts of Systematic Reviews, Meta-analyses & Network Meta-analyses
 
Osteoarthriits Imaging: 2018 Year in Review
Osteoarthriits Imaging: 2018 Year in ReviewOsteoarthriits Imaging: 2018 Year in Review
Osteoarthriits Imaging: 2018 Year in Review
 
Vincent the Lumper!
Vincent the Lumper!Vincent the Lumper!
Vincent the Lumper!
 
OA White Paper: Broader Implications for Advocacy, Health Policy & Research
OA White Paper: Broader Implications for Advocacy, Health Policy & ResearchOA White Paper: Broader Implications for Advocacy, Health Policy & Research
OA White Paper: Broader Implications for Advocacy, Health Policy & Research
 
Structural Targets for Prevention of Post Traumatic OA
Structural Targets for Prevention of Post Traumatic OAStructural Targets for Prevention of Post Traumatic OA
Structural Targets for Prevention of Post Traumatic OA
 
Building a translational team for impacting public policy Pre-Congress Worksh...
Building a translational team for impacting public policyPre-Congress Worksh...Building a translational team for impacting public policyPre-Congress Worksh...
Building a translational team for impacting public policy Pre-Congress Worksh...
 
An industry point of view for building a translational team
An industry point of view for building a translational teamAn industry point of view for building a translational team
An industry point of view for building a translational team
 
Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, a...
Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, a...Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, a...
Osteoarthritis: Structural Endpoints for the Development of Drugs, Devices, a...
 
Understanding the Accelerated Pathway
Understanding the Accelerated PathwayUnderstanding the Accelerated Pathway
Understanding the Accelerated Pathway
 
Approval of Therapeutics for Osteoarthritis in 2019
Approval of Therapeutics for Osteoarthritis in 2019Approval of Therapeutics for Osteoarthritis in 2019
Approval of Therapeutics for Osteoarthritis in 2019
 
YEAR IN REVIEW - Genetics, Genomics, Epigenetics
YEAR IN REVIEW - Genetics, Genomics, EpigeneticsYEAR IN REVIEW - Genetics, Genomics, Epigenetics
YEAR IN REVIEW - Genetics, Genomics, Epigenetics
 
Year in review - Biochemical markers
Year in review - Biochemical markersYear in review - Biochemical markers
Year in review - Biochemical markers
 
Year in Review: Mechanics
Year in Review: MechanicsYear in Review: Mechanics
Year in Review: Mechanics
 
Rehabilitation and Outcomes - Year in Review
Rehabilitation and Outcomes - Year in ReviewRehabilitation and Outcomes - Year in Review
Rehabilitation and Outcomes - Year in Review
 
Clinical OA: Epidemiology and Therapy - Year in Review
Clinical OA: Epidemiology and Therapy - Year in ReviewClinical OA: Epidemiology and Therapy - Year in Review
Clinical OA: Epidemiology and Therapy - Year in Review
 
2020 OA Vision: Emerging Therapeutics on the OA landscape
2020 OA Vision: Emerging Therapeutics on the OA landscape2020 OA Vision: Emerging Therapeutics on the OA landscape
2020 OA Vision: Emerging Therapeutics on the OA landscape
 
Is osteoarthritis one disease or many?
Is osteoarthritis one disease or many? Is osteoarthritis one disease or many?
Is osteoarthritis one disease or many?
 
Early OA OUTCOMES: What should the targets be?
Early OA OUTCOMES:  What should the targets be?Early OA OUTCOMES:  What should the targets be?
Early OA OUTCOMES: What should the targets be?
 

Wnt in Bone and Cartilage

Editor's Notes

  1. Wnt is regulated by endogenous antagonists among them Sclerostin which is a protein mainly produced by osteocytes. Many studies show an effect of bone remodeling on cartilage homeostasis. Therefore, in the present work, we assess the role of Sclerostin in cartilage maintenance and in OA.
  2. Inhibition of the Wnt/B-catenin pathway by Sclerostin abolished the metalloproteinases increase induced by wnt and had a slight effect on the differentiation gene regulation. And finally Sclerostin was able to inhibit the hypertrophic phenotype induced by Wnt.